The foundation of AD therapy is repairing the skin barrier to reduce triggers and prevent flares.
: These are essential for all patients, even during remission. ATOPIC DERMATITIS THERAPY
Narrowband UVB (311 nm) or UVA1 phototherapy serves as an adjuvant for moderate-to-severe disease that is refractory to topicals. It has antimicrobial effects and modulates the skin's immune response. The foundation of AD therapy is repairing the
: Tacrolimus (ointment) and pimecrolimus (cream) are steroid-sparing alternatives particularly useful for sensitive areas like the face or skin folds. Newer Topicals : Crisaborole : A PDE-4 inhibitor for mild-to-moderate AD. It has antimicrobial effects and modulates the skin's
: At least twice daily, ideally within three minutes of bathing to lock in moisture.
: Ointments and creams are generally superior to lotions for barrier repair. Newer formulations may include ceramides or filaggrin breakdown products.
